SWM
NVO

Silverlake Wealth Management’s Novo Nordisk NVO Stock Holding History

Silverlake Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$204K Buy
+4,249
New +$183K 0.04% 377
2024
Q3 		– Sell
-1,638
Closed -$234K – 294
2024
Q2 		$234K Buy
+1,638
New +$217K 0.1% 235

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Silverlake Wealth Management's NVO Position: Q2 2026 in Review

Silverlake Wealth Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,249 shares worth $204K. The stake represents 0.04% of the portfolio and ranks #377 among its holdings. This is a return to the name: Silverlake Wealth Management previously reported a position in NVO as recently as Q2 2024.

Silverlake Wealth Management first reported a position in NVO in Q2 2024 and has held it in 2 quarters since. The position peaked at $234K in Q2 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Silverlake Wealth Management held 4,249 shares of Novo Nordisk worth $204K as of Q2 2026.
  • Novo Nordisk was a new Silverlake Wealth Management position in Q2 2026.
  • Novo Nordisk made up 0.04% of Silverlake Wealth Management's portfolio in Q2 2026, its #377 holding.
  • Silverlake Wealth Management first reported a position in Novo Nordisk in Q2 2024 and has held it in 2 quarters since.
  • Silverlake Wealth Management's Novo Nordisk position peaked at $234K in Q2 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Silverlake Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.